The Selective Estrogen Receptor Modulator, Raloxifene: A Segment II/III Delivery Study in Rats 11This study (except for immune system assessments) was conducted in accordance with the FDA’s Good Laboratory Practices for Nonclinical Laboratory Studies [1].

Publication | Closed Access

DOI

Citations

References

1998

Year

Judy Buelke‐Sam, Ilene R. Cohen, Daniel Wierda, Kelly I. Griffey, Lawrence F. Fisher, Paul C. Francis

Reproductive Toxicology

Molecular PharmacologyImmune System AssessmentsMedicineHormonal ReceptorUterine ReceptivityGynecologyRats 11ThisMenopause Hormone TherapyPharmacotherapyFemale Reproductive FunctionGood Laboratory PracticesEndocrinologyPharmacologyEndocrine ResearchPre-clinical PharmacologyReproductive Endocrinology